Breadcrumb Investment Banking Transactions ImmunityBio - 2024/12/10 Equity Capital Markets ImmunityBio 12/24 | $100.0 Million Piper Sandler served as bookrunner for ImmunityBio, Inc. on its CMFO Sub-Type CMFO Sector Healthcare Sub-Sector Biopharma